News

Our partners are building great companies.

We love to share their stories.

Join the Conversation

A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more @LyndraInc statnews.com/2018/11/15/sic…

.@gausssurgical Raises $20 million in Series C for AI-Enabled Platform for the Operating Room prnewswire.com/news-releases/…

AbbVie Commits $100M to @MorphicTx in Fibrosis Drug R&D Alliance xconomy.com/boston/2018/10…

Roche doubles down on a $1.37B-plus deal with @SQZBiotech for a new approach to immuno-oncology endpts.com/sqz-play-roche…

.@PolarisVC partner @Egnyte @CloudNotEnough Takes $75 Million in Late-Stage Funding from Goldman blogs.wsj.com/cio/2018/10/10… via @WSJ

Glympse Bio Raises $22m Series A Financing to Fund Novel Model for Sensing Diseases businesswire.com/news/home/2018…